OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

204

Participants

Timeline

Start Date

September 27, 2022

Primary Completion Date

November 22, 2024

Study Completion Date

December 26, 2024

Conditions

Open Angle Glaucoma or Ocular Hypertension

Interventions

DRUG

OPC-1085EL

one drop for each eye, once per day

DRUG

0.005% Latanoprost

one drop for each eye, once per day

Trial Locations (1)

Eye & ENT Hospital of Fudan University, Shanghai